MENU
GLMD
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Galmed Pharmaceuticals (GLMD) Ownership - Who owns Galmed Pharmaceuticals?

Profile

Industry
Pharmaceuticals Other
Address
16 Tiomkin Street
Phone
+972 36938448
Employees
10
Web
https://www.galmedpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.05M
P/E Ratio
0.04
Total Cash
17.14M
Projected Growth
N/A
Total Debt
41K
Revenue
N/A
Risk (Beta)
-0.11
Dividend Yield
N/A
Total Cash/Share
10.34
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

GLMD
Capitalization
5.05M
P/E Ratio
0.04
Risk (Beta)
-0.11
Dividend Yield
N/A
Total Cash
17.1M
Total Cash/Share
10.34
Total Debt
41K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
18.4M
P/B Ratio
0.27
Cash Flow
N/A
Earnings
69.72
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
665K
Current Ratio
7.03
Current Revenue Per Employee
88235.30
Dividends Per Share - Security
N/A
EBITDA
-6.7M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-32.78
Shares Held By Institutions
57.5K
Shares Outstanding - Current
1.66M
Total Liabilities
2.51M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-44.139
View a ticker or compare two or three
GLMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a manufacturer of pharmaceutical products

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
16 Tiomkin Street
Phone
+972 36938448
Employees
10
Web
https://www.galmedpharma.com